@curator

7 months ago

Article

Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications - The Pharmacogenomics Journal

Rating: 0.0

Likes: 1

Library: 1

Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications - The Pharmacogenomics Journal

Epilepsy treatment is challenging due to heterogeneous syndromes, different seizure types and higher inter-individual variability. Identification of genetic variants predicting drug efficacy, tolerability and risk of adverse-effects for anti-seizure medications (ASMs) is essential. Here, we assessed the clinical actionability of known genetic variants, based on their functional and clinical significance and estimated their diagnostic predictability.

Rate This Post

Rate The Educational Value

Rate The Ease of Understanding and Presentation

Interesting or Boring? Rate the Entertainment Value

Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications - The Pharmacogenomics Journal

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge
for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge
for Humanity's Progress

Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications - The Pharmacogenomics Journal

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress